Arvee Laboratories (India) (ARVEE): Arvee Laboratories Share Price Falls 9.35% Today to Rs 177
- September 11, 2026
- Posted by: Harsh Piplani
- Category: News
Arvee Laboratories Share Price fell to Rs 177 on 11 September 2026, down 9.35% for the day from the previous close of Rs 195.25. The stock was lower by Rs 18.25 in the session, while the company’s market capitalisation stood at Rs 215.17 crore. In today’s market action, the move stands out because the company is a Micro Cap stock in the Chemicals industry and the decline happened within a relatively tight intraday price band near the lower end of the day’s range.
The supplied data confirms the price move but does not provide any company-specific trigger for it. That means the update should be read as a factual market snapshot rather than a conclusion about a business event. Even so, the stock remains relevant because the one-day decline comes alongside a valuation of 53.15 times earnings and 6.06 times book value, with ROE at 7.11% and ROCE at 10%.
The company is benchmarked within the Chemicals industry, where Univest’s same-industry dataset spans 178 companies. That allows today’s decline to be viewed not only as price action, but also through the lens of valuation, profitability and relative scale versus peers.
Arvee Laboratories (India) (ARVEE) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 177 |
| Previous Close | Rs 195.25 |
| Today's Move | -Rs 18.25 (-9.35%) |
| Open | Rs 195 |
| High | Rs 195 |
| Low | Rs 176.5 |
| Turnover | Rs 0.13 crore |
| Market Capitalisation | Rs 215.17 crore |
| Market Cap Category | Micro Cap |
Arvee Laboratories Share Price Today shows a weak session structure from start to finish. The stock opened at Rs 195, almost flat against the previous close of Rs 195.25, and that opening level also turned out to be the day’s high. From there, the stock moved lower to an intraday low of Rs 176.5 and was trading at Rs 177 at the time of this update.
That pattern matters because it shows the stock did not recover above the opening zone during the session. When a stock opens near the prior close, fails to move above the open, and remains close to the day’s low, traders usually read that as sustained intraday weakness rather than a brief downward spike. Turnover stood at Rs 0.13 crore, which is modest in absolute terms but still notable in a micro-cap counter.
For anyone tracking Arvee Laboratories Share Price as a live market move, the session data alone explains why the stock is drawing attention: the decline was not only large in percentage terms, it also unfolded with the high fixed at the open and the last traded level near the low.
Arvee Laboratories (India) (ARVEE) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 215.17 crore |
| P/E Ratio | 53.15x |
| P/B Ratio | 6.06x |
| ROE | 7.11% |
| ROCE | 10% |
| EPS | Rs 3.67 |
| Book Value Per Share | Rs 32.2 |
| Dividend Yield | 0% |
The available fundamentals suggest a business with positive profitability, but not an especially high-return profile on the metrics supplied here. At the same time, valuation multiples remain elevated. That contrast is one reason today’s stock move is being watched closely.
The company trades at a P/E ratio of 53.15 and a P/B ratio of 6.06. EPS stands at Rs 3.67 and book value per share at Rs 32.2. Dividend yield is listed at 0, so the supplied data does not show any current dividend support. These numbers do not explain the day’s decline by themselves, but they do shape how investors may interpret it.
On profitability, ROE is 7.11% and ROCE is 10%. Those are positive returns, yet they are not unusually strong versus the wider listed chemicals space. In simple terms, the stock is trading on valuation levels that appear relatively firm, while return ratios look more moderate. That balance is important when assessing Arvee Laboratories Share Price after a sharp single-session fall.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Chemicals |
| Industry | Chemicals |
| Benchmark Scope | same industry |
| Company P/E Ratio | 53.15x |
| Benchmark Median P/E | 26.89x |
| Benchmark Average P/E | 51.05x |
| Benchmark P/E Range | 4.59x to 768.73x |
| Company P/B Ratio | 6.06x |
| Benchmark Median P/B | 1.96x |
| Benchmark Average P/B | 2.62x |
| Company ROE | 7.11% |
| Benchmark Median ROE | 7.68% |
| Benchmark Average ROE | -2.92% |
| Company ROCE | 10% |
| Benchmark Median ROCE | 9.78% |
| Benchmark Average ROCE | 18.29% |
| Company Market Capitalisation | Rs 215.17 crore |
| Benchmark Median Market Cap | Rs 490.5 crore |
| Benchmark Average Market Cap | Rs 5,524.19 crore |
The industry comparison shows that the stock is priced above median sector valuation levels. Its P/E of 53.15 is well above the chemicals median of 26.89 and slightly above the average of 51.05, based on 152 companies with available P/E data. The industry range is wide, from 4.59 to 768.73, so the stock is not at the extreme top, but it is clearly on the richer side versus the median.
The same is true on price-to-book. The company’s P/B of 6.06 compares with a median of 1.96 and an average of 2.62 across 177 companies. On returns, ROE of 7.11% is a little below the sector median of 7.68%, while ROCE of 10% is just above the median of 9.78% but below the average of 18.29. In market-cap terms, Rs 215.17 crore is below the industry median of Rs 490.5 crore and far below the average of Rs 5,524.19 crore.
Taken together, the benchmark suggests a smaller chemicals company trading at above-median valuation multiples without a large profitability premium over the sector median. That does not determine what happens next, but it does provide context for why the stock’s decline is being examined closely today.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Solar Industries India | SOLARINDS | 2,01,838.07 | 101.74 | 29.22 | 32.49 | 38.16 |
| Pidilite Industries | PIDILITIND | 1,60,061.58 | 60.29 | 13.81 | 24.29 | 32.38 |
| SRF | SRF | 74,550.84 | 34.39 | 5.03 | 13.8 | 14.21 |
| Gujarat Fluorochemicals | FLUOROCHEM | 52,220.49 | 85.9 | 6.58 | 7.65 | 9.58 |
| Navin Fluorine International | NAVINFLUOR | 45,131.39 | 56.51 | 10.63 | 20.24 | 21.39 |
The named peers in the dataset are all much larger companies. Solar Industries India has a market cap of Rs 2,01,838.07 crore, Pidilite Industries Rs 1,60,061.58 crore, SRF Rs 74,550.84 crore, Gujarat Fluorochemicals Rs 52,220.49 crore and Navin Fluorine International Rs 45,131.39 crore. Against that set, Arvee Laboratories is much smaller at Rs 215.17 crore.
Valuation-wise, the stock’s P/E of 53.15 is below Solar Industries, Pidilite, Gujarat Fluorochemicals and Navin Fluorine, but above SRF. Its P/B of 6.06 is above SRF’s 5.03 and below Gujarat Fluorochemicals’ 6.58 as well as the higher multiples of Solar, Pidilite and Navin Fluorine. On profitability, ROE at 7.11% and ROCE at 10% trail most of these peers, with ROCE only slightly above Gujarat Fluorochemicals’ 9.58%.
This comparison does not imply equivalence between businesses of very different scale, but it does show that the stock’s valuation is not especially low even though its size and return profile are more modest than those of the larger peer group.
Why Investors Are Watching Arvee Laboratories
- The stock fell 9.35% in one session, from Rs 195.25 to Rs 177.
- The day’s high matched the open at Rs 195, while the low was Rs 176.5.
- Valuation remains above industry medians, with P/E at 53.15 and P/B at 6.06.
- ROE of 7.11% and ROCE of 10% indicate positive but moderate profitability.
- The company sits in a same-industry comparison set of 178 chemicals companies, giving investors a useful benchmark.
About Arvee Laboratories
Arvee Laboratories (India) is classified in the Chemicals sector and Chemicals industry in the supplied dataset. Based on the available market data, the company is best understood as a listed micro-cap chemicals business with a market capitalisation of Rs 215.17 crore, rather than as a large-cap sector leader.
Its current profile in the dataset combines a P/E of 53.15, P/B of 6.06, ROE of 7.11%, ROCE of 10%, EPS of Rs 3.67 and book value per share of Rs 32.2. That makes relative valuation and profitability comparison central to any discussion of the stock.
Track Arvee Laboratories Share Price on Univest
UseArvee Laboratories (India) (ARVEE) live share-price page,Univest top decliners screener,Univest market blogsto review live stock data, top decliners and related market analysis.
Investors can track Arvee Laboratories Share Price on Univest alongside valuation ratios, peer metrics, market cap, EPS, book value and broader sector context so that a sharp one-day move can be viewed in a fuller analytical framework.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Arvee Laboratories Share Price fall today?
Ans. Arvee Laboratories Share Price fell 9.35% to Rs 177 on 11 September 2026. The supplied data confirms the decline from the previous close of Rs 195.25, but it does not identify a company-specific catalyst.
How do the profitability metrics compare with the industry?
Ans. ROE is 7.11%, slightly below the industry median of 7.68%, while ROCE is 10%, slightly above the median of 9.78%. The stock belongs to the Chemicals sector. Its industry classification is Chemicals.
How does it compare with major chemicals peers?
Ans. It is much smaller by market cap than the supplied peers such as Solar Industries, Pidilite, SRF, Gujarat Fluorochemicals and Navin Fluorine. Its valuation is above SRF on P/E but below several other peers, while its ROE and ROCE are.
